Pretreatment Reward Sensitivity and Frontostriatal Resting-State Functional Connectivity Are Associated With Response to Bupropion After Sertraline Nonresponse
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Background Standard guidelines recommend selective serotonin reuptake inhibitors (SSRIs) as first-line antidepressants for adults with Major Depressive Disorder (MDD), but success is limited and patients who fail to benefit are often switched to non-SSRI agents. This study investigated whether brain and behavior-based markers of reward processing might be associated with response to bupropion after sertraline nonresponse. Methods In a two-stage, double-blinded clinical trial (Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care), 296 participants were randomized to receive 8 weeks of sertraline or placebo in Stage 1. Individuals who responded continued on another 8-week course of the same intervention in Stage 2, while sertraline and placebo non-responders crossed-over to bupropion and sertraline, respectively. Data from 241 participants were analyzed. The Stage 2 sample comprised 87 MDD patients who switched medication and 38 healthy controls. 116 MDD participants treated with sertraline in Stage 1 served as an independent replication sample. The probabilistic reward task and resting-state functional magnetic resonance imaging were administered at baseline. Results Greater pretreatment reward sensitivity, as well as higher resting-state functional connectivity between bilateral nucleus accumbens and rostral anterior cingulate cortex, were associated with positive response to bupropion, but not sertraline. Null findings for sertraline were replicated in the Stage 1 sample. Conclusion Pretreatment reward sensitivity and frontostriatal connectivity may identify patients likely to benefit from bupropion following SSRI failures. Results call for a prospective replication based on these biomarkers to advance clinical care. Trial registration clinicaltrials.gov Identifier: NCT01407094
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Self-citationAnticipation of Increasing Monetary Reward Selectively Recruits Nucleus Accumbens
Knutson, B., Adams, C. M., Fong, G. W., & Hommer, D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-16-j0002.2001 · Cited by 2,244
The mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059 · cited 2×
“These findings contrast with our original hypotheses, which were originally derived from the assumptions that 1) SSRIs poorly address anhedonic phenotypes (81) and 2) patients with behavioral and neural markers indexing blunted reward processing would disproportionally benefit from pharmacological treatment assumed to…”
BackgroundResultThe Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)
Greenberg, P. E., Fournier, A.-A., Sisitsky, T., Pike, C. T., & Kessler, R. C. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09298 · Cited by 1,779
The incentive sensitization theory of addiction: some current issues
Robinson, T. E., & Berridge, K. C. (2008) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2008.0093 · Cited by 1,717
The role of dopamine in the pathophysiology of depression
Dunlop, B. W., & Nemeroff, C. B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.3.327 · Cited by 1,244 · cited 3×
“As such, it has been suggested that sertraline might inhibit the reuptake of dopamine, particularly at high doses of 200 mg and above (63).”
BackgroundResultDepression, Stress, and Anhedonia: Toward a Synthesis and Integrated Model
Pizzagalli, D. A. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050212-185606 · Cited by 1,155 · cited 1×
“This limited success partially stems from the fact that treatment selection is not based on identification of the underlying biomarker abnormality that reflects pathophysiology (7,8).”
BackgroundSelf-citationBupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Stewart, J. W., Nierenberg, A. A., Thase, M. E., Ritz, L., Biggs, M. M., Warden, D., Luther, J. F., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052963 · Cited by 1,033
Self-citationMedication Augmentation after the Failure of SSRIs for Depression
Trivedi, M. H., Fava, M., Wisniewski, S. R., Thase, M. E., Quitkin, F., Warden, D., Ritz, L., Nierenberg, A. A., Lebowitz, B. D., Biggs, M. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052964 · Cited by 1,002
Self-citationFrontocingulate Dysfunction in Depression: Toward Biomarkers of Treatment Response
Pizzagalli, D. A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.166 · Cited by 945
Self-citation
Cited by
Anhedonia in depression and bipolar disorder
Whitton, A. E., & Pizzagalli, D. A. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_323 · Cited by 80
Intrinsic Connectivity Networks of Glutamate-Mediated Antidepressant Response: A Neuroimaging Review
Demchenko, I., Tassone, V. K., Kennedy, S. H., Dunlop, K., & Bhat, V. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.864902 · Cited by 29
Ang, Y.-S., Bruder, G. E., Keilp, J. G., Rutherford, A., Alschuler, D. M., Pechtel, P., Webb, C. A., Carmody, T., Fava, M., Cusin, C., et al. (2022) · Psychological Medicine · doi:10.1017/s0033291720004286 · Cited by 12
Self-citation
Metadata
- Authors
- Ang, Y.-S., Kaiser, R., Deckersbach, T., Almeida, J., Phillips, M. L., Chase, H. W., Webb, C. A., Parsey, R., Fava, M., McGrath, P., Weissman, M., Adams, P., Deldin, P., Oquendo, M. A., McInnis, M. G., Carmody, T., Bruder, G., Cooper, C. M., Chin Fatt, C. R., Trivedi, M. H., & Pizzagalli, D. A.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2020-10
- Volume
- 88
- Issue
- 8
- Pages
- 657-667
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W3020698841
- Cited by
- 43
- References
- 47
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pretreatment Reward Sensitivity and Frontostriatal Resting-State Functional Connectivity Are Associated With Response to Bupropion After Sertraline Nonresponse. https://app.cochat.ai/papers/10.1016/j.biopsych.2020.04.009
- The paper
- Ang, Y.-S., Kaiser, R., Deckersbach, T., Almeida, J., Phillips, M. L., Chase, H. W., Webb, C. A., Parsey, R., Fava, M., McGrath, P., Weissman, M., Adams, P., Deldin, P., Oquendo, M. A., McInnis, M. G., Carmody, T., Bruder, G., Cooper, C. M., Chin Fatt, C. R., . . . Pizzagalli, D. A. (2020). Pretreatment Reward Sensitivity and Frontostriatal Resting-State Functional Connectivity Are Associated With Response to Bupropion After Sertraline Nonresponse. Biological Psychiatry. https://doi.org/10.1016/j.biopsych.2020.04.009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.